SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BOLDEA LUCIAN

(Last)

(First)

(Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT

37660

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2016

3. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	694	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	02/26/2017⁽¹⁾	02/25/2026	Common Stock	10,427	$65.16	D
Employee Stock Option (right to buy)	02/27/2016⁽²⁾	02/26/2025	Common Stock	5,499	$74.46	D
Employee Stock Option (right to buy)	02/28/2015⁽³⁾	02/27/2024	Common Stock	3,267	$87.43	D
Employee Stock Option (right to buy)	02/28/2016	02/27/2023	Common Stock	4,118	$69.73	D
Restricted Stock Units	01/31/2018⁽⁴⁾	01/31/2018⁽⁴⁾	Common Stock	4,450	⁽⁴⁾	D

Explanation of Responses:

1. One third of option becomes exercisable on each of February 26, 2017, February 26, 2018 and February 26, 2019.

2. One third of option became exercisable on February 27, 2016 and one third of option becomes exercisable on each of February 27, 2017 and February 27, 2018.

3. One third of option became exercisable on each of February 28, 2015 and February 28, 2016 and one third of option becomes exercisable on February 28, 2017.

4. Each restricted stock unit represents a contingent right to receive one share of issuer common stock subject to continued employment.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian L. Henry by Power of Attorney	07/07/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.